Follow
Idogen AB
Spotlight (Sweden)
Idogen is a research company. The company's business focus is on developing vaccines for the treatment of diseases that adversely affect the immune system. The vaccines are intended to be used in the cases where autoimmune diseases have occurred and after organ rejection, particularly in the cases where antibodies have been formed against the ingestion of the regular medication of the patient. The company was founded in 2008 and is based in Lund.
Sector:
HEALTH CARE
Media
Current instruments
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
IDOGEN
SE0014428561
Spotlight
Sweden (SE)
Details of share in Idogen AB with ticker IDOGEN
Status
Active
Order book id
4134
Amount of instruments
9 121 654
Par value
0.7000
Market cap
54 800 000.00 SEK
Currency
SEK
First trading date
12 Jun 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
6.85 SEK
49.9M SEK
23 Apr - 08 May 2015
IPO in Idogen AB
Market
Spotlight
Subscription period
23 Apr - 08 May 2015
Subscription price
6.85 SEK
Price per share
6.85 SEK
Target to raise
17 125 000 SEK
Types
Pre-money valuation
49 900 000 SEK
Subscription block size
Minimum subscription
800
Record date
Offer status
Closed
Listing status
Listed
First trading date
12 Jun 2015
Issue terms
Type
Price
Pre-money valuation
Time
Files
Exercise
08 Sep - 29 Sep 2016
Option exercise terms for IDOGEN TO1
Market
Spotlight
Exercise period(s)
08 Sep - 29 Sep 2016
Exercise price
Status
Closed
Issue terms
Type
Price
Pre-money valuation
Time
Files
New issue
6.00 SEK
73.3M SEK
24 May - 12 Jun 2017
Share issue in Idogen AB
Market
Spotlight
Subscription period
24 May - 12 Jun 2017
Subscription price
42.00 SEK
Price per share
6.00 SEK
Target to raise
64 200 000 SEK
Types
Share issue
Pre-money valuation
73 300 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption right 7:8. One (1) unit right is obtained for each existing share. Eight (8) unit rights entitle to subscribe for one (1) unit. Each unit consists of seven (7) shares and seven (7) warrants of series TO2 and seven (7) warrants of series TO3.
Type
Price
Pre-money valuation
Time
Files
Exercise
03 May - 18 May 2018
-
Option exercise terms for IDOGEN TO2
Market
Spotlight
Exercise period(s)
03 May - 18 May 2018
Exercise price
Status
Closed
Issue terms
Type
Price
Pre-money valuation
Time
Files
New issue
1.75 SEK
36M SEK
20 Nov - 05 Dec 2018
Share issue in Idogen AB
Market
Spotlight
Subscription period
20 Nov - 05 Dec 2018
Subscription price
1.75 SEK
Price per share
1.75 SEK
Target to raise
60 600 000 SEK
Types
Share issue
Pre-money valuation
36 000 000 SEK
Subscription block size
Minimum subscription
Record date
14 Nov 2018
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption right 5:3. Each existing share entitles one (1) subscription right and three (3) subscription rights entitle to subscribe for five (5) new shares.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.00 SEK
19 Mar - 01 Apr 2019
-
Option exercise terms for IDOGEN TO3
Market
Spotlight
Exercise period(s)
19 Mar - 01 Apr 2019
Exercise price
6.00 SEK
Status
Closed
Issue terms
Update: The price was set at the lowest possible price 6 SEK. As this is multiple times higher then the market price nobody should excercise their options.

Each 1 option gives the holder the right to subscribe for 1 new share. The exercise price is set as 70 % of the volume weighted average market price during 25 February - 15 March 2019. But now lower than 6 SEK and not higher than 13 SEK.
Type
Price
Pre-money valuation
Time
Files
New issue
0.60 SEK
29.1M SEK
02 Mar - 16 Mar 2020
Share issue in Idogen AB
Market
Spotlight
Subscription period
02 Mar - 16 Mar 2020
Subscription price
0.60 SEK
Price per share
0.60 SEK
Target to raise
29 100 000 SEK
Types
Share issue
Pre-money valuation
29 100 000 SEK
Subscription block size
Minimum subscription
Record date
26 Feb 2020
Offer status
Closed
Listing status
Listed
Issue terms
The right to subscribe for shares shall, with preferential right, be granted to those who are registered as shareholders in the Company on the record date for the Rights Issue, whereby holding one (1) existing share in the Company entitles one (1) subscription right and one (1) subscription right to subscribe for one (1) new share.
Comments for offer & related information
The company shall issue a maximum of 48 491 533 shares. In conjunction with the Rights Issue, members of the Board of Directors and management have submitted subscription intentions totaling SEK 635,000, corresponding to approximately 2 percent of the rights issue. In addition, the Company has entered into an agreement with a number of external investors on issue guarantees amounting to SEK 24.5 million, corresponding to approximately 86 percent of the Rights Issue. Cash commission is paid according to the guarantee agreements of ten per cent on guaranteed amount, corresponding to a total of SEK 2.5 million. All in all, the Rights Issue is thus covered by subscription intentions and guarantee commitments amounting to approximately SEK 25 M, corresponding to approximately 88 percent of the Rights Issue.
Result of offer
Right issue has been subscribed to approximately 88 percent, which implies that Idogen will raise SEK 25,6M.
Type
Price
Pre-money valuation
Time
Files
Market move
04 Jun 2020
Listing of Idogen AB on Nasdaq First North Sweden
Move from
Spotlight
Move to
Nasdaq First North Sweden
Status
Upcoming
Comments for listing & related information
Idogen will be listed on Nasdaq Stockholm First North Growth Market on June 4, 2020.
Documents
Type
Ticker
ISIN
Market
SHARE
IDOGEN
SE0006887386
Spotlight
Sweden (SE)
Details of share in Idogen AB with ticker IDOGEN
Status
Archived
Order book id
4134
Amount of instruments
91 216 533
Par value
0.0700
Market cap
56 400 000.00 SEK
Currency
SEK
First trading date
12 Jun 2015
Terms
Update (20.05.2020): Company’s ISIN code will change as a result of the consolidation of shares (1:10).
Type
Price
Pre-money valuation
Time
Files
IPO
6.85 SEK
49.9M SEK
23 Apr - 08 May 2015
IPO in Idogen AB
Market
Spotlight
Subscription period
23 Apr - 08 May 2015
Subscription price
6.85 SEK
Price per share
6.85 SEK
Target to raise
17 125 000 SEK
Types
Pre-money valuation
49 900 000 SEK
Subscription block size
Minimum subscription
800
Record date
Offer status
Closed
Listing status
Listed
First trading date
12 Jun 2015
Issue terms
Type
Price
Pre-money valuation
Time
Files
New issue
6.00 SEK
73.3M SEK
24 May - 12 Jun 2017
Share issue in Idogen AB
Market
Spotlight
Subscription period
24 May - 12 Jun 2017
Subscription price
42.00 SEK
Price per share
6.00 SEK
Target to raise
64 200 000 SEK
Types
Share issue
Pre-money valuation
73 300 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption right 7:8. One (1) unit right is obtained for each existing share. Eight (8) unit rights entitle to subscribe for one (1) unit. Each unit consists of seven (7) shares and seven (7) warrants of series TO2 and seven (7) warrants of series TO3.
Type
Price
Pre-money valuation
Time
Files
New issue
1.75 SEK
36M SEK
20 Nov - 05 Dec 2018
Share issue in Idogen AB
Market
Spotlight
Subscription period
20 Nov - 05 Dec 2018
Subscription price
1.75 SEK
Price per share
1.75 SEK
Target to raise
60 600 000 SEK
Types
Share issue
Pre-money valuation
36 000 000 SEK
Subscription block size
Minimum subscription
Record date
14 Nov 2018
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption right 5:3. Each existing share entitles one (1) subscription right and three (3) subscription rights entitle to subscribe for five (5) new shares.
Type
Price
Pre-money valuation
Time
Files
New issue
0.60 SEK
29.1M SEK
02 Mar - 16 Mar 2020
Share issue in Idogen AB
Market
Spotlight
Subscription period
02 Mar - 16 Mar 2020
Subscription price
0.60 SEK
Price per share
0.60 SEK
Target to raise
29 100 000 SEK
Types
Share issue
Pre-money valuation
29 100 000 SEK
Subscription block size
Minimum subscription
Record date
26 Feb 2020
Offer status
Closed
Listing status
Listed
Issue terms
The right to subscribe for shares shall, with preferential right, be granted to those who are registered as shareholders in the Company on the record date for the Rights Issue, whereby holding one (1) existing share in the Company entitles one (1) subscription right and one (1) subscription right to subscribe for one (1) new share.
Comments for offer & related information
The company shall issue a maximum of 48 491 533 shares. In conjunction with the Rights Issue, members of the Board of Directors and management have submitted subscription intentions totaling SEK 635,000, corresponding to approximately 2 percent of the rights issue. In addition, the Company has entered into an agreement with a number of external investors on issue guarantees amounting to SEK 24.5 million, corresponding to approximately 86 percent of the Rights Issue. Cash commission is paid according to the guarantee agreements of ten per cent on guaranteed amount, corresponding to a total of SEK 2.5 million. All in all, the Rights Issue is thus covered by subscription intentions and guarantee commitments amounting to approximately SEK 25 M, corresponding to approximately 88 percent of the Rights Issue.
Result of offer
Right issue has been subscribed to approximately 88 percent, which implies that Idogen will raise SEK 25,6M.
Type
Price
Pre-money valuation
Time
Files
Market move
04 Jun 2020
Listing of Idogen AB on Nasdaq First North Sweden
Move from
Spotlight
Move to
Nasdaq First North Sweden
Status
Upcoming
Comments for listing & related information
Idogen will be listed on Nasdaq Stockholm First North Growth Market on June 4, 2020.
Documents
Type
Ticker
ISIN
Market
SHARE
IDOGEN
SE0014428561
Spotlight
Sweden (SE)
Details of share in Idogen AB with ticker IDOGEN
Status
Active
Order book id
4134
Amount of instruments
9 121 654
Par value
0.7000
Market cap
54 800 000.00 SEK
Currency
SEK
Terms
Type
Ticker
ISIN
Market
OPTION
IDOGEN TO1
SE0006887394
Spotlight
Sweden (SE)
Details of option in Idogen AB with ticker IDOGEN TO1
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Type
Price
Pre-money valuation
Time
Files
Exercise
08 Sep - 29 Sep 2016
Option exercise terms for IDOGEN TO1
Market
Spotlight
Exercise period(s)
08 Sep - 29 Sep 2016
Exercise price
Status
Closed
Issue terms
Type
Ticker
ISIN
Market
OPTION
IDOGEN TO2
SE0009895618
Spotlight
Sweden (SE)
Details of option in Idogen AB with ticker IDOGEN TO2
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Type
Price
Pre-money valuation
Time
Files
Exercise
03 May - 18 May 2018
-
Option exercise terms for IDOGEN TO2
Market
Spotlight
Exercise period(s)
03 May - 18 May 2018
Exercise price
Status
Closed
Issue terms
Type
Ticker
ISIN
Market
OPTION
IDOGEN TO3
SE0009895626
Spotlight
Sweden (SE)
Details of option in Idogen AB with ticker IDOGEN TO3
Status
Archived
Order book id
40YB
Amount of instruments
1
Market cap
Currency
SEK
First trading date
Terms
Update: The price was set at the lowest possible price 6 SEK. As this is multiple times higher then the market price nobody should excercise their options.

Each 1 option gives the holder the right to subscribe for 1 new share. The exercise price is set as 70 % of the volume weighted average market price during 25 February - 15 March 2019. But now lower than 6 SEK and not higher than 13 SEK.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.00 SEK
19 Mar - 01 Apr 2019
-
Option exercise terms for IDOGEN TO3
Market
Spotlight
Exercise period(s)
19 Mar - 01 Apr 2019
Exercise price
6.00 SEK
Status
Closed
Issue terms
Update: The price was set at the lowest possible price 6 SEK. As this is multiple times higher then the market price nobody should excercise their options.

Each 1 option gives the holder the right to subscribe for 1 new share. The exercise price is set as 70 % of the volume weighted average market price during 25 February - 15 March 2019. But now lower than 6 SEK and not higher than 13 SEK.
People
Anders Karlsson
CEO
Agneta Edberg
Chairman of the board
Christina Herder
Board member
Leif G Salford
Board member
Sharon Longhurst
Board member
Company Details
Sector
HEALTH CARE
Website

Address
C/O Medicon Village
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Registration number
556756-8521
LEI code
549300ERF656YVUYXS32
First trade date
12 Jun 2015
Registration date
24 Apr 2008
Short name
Idogen

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date